Objectives: The objective of this study was to determine the safety and efficacy of intracardiac echocardiography (ICE) to guide percutaneous paravalvular leak (PVL) closure.
risk patient group, both general anesthesia and TOE may be associated with significant additional risk (e.g., due to the presence of significant lung disease) or contraindicated (e.g., presence of esophageal varices) independent of the PVL closure procedure itself. Intracardiac echocardiography (ICE) provides high-resolution real-time imaging without the requirement for general anesthesia or esophageal intubation and for septal defect closure has been associated with shorter procedure and fluoroscopic times [15] . Its use in a frailer PVL closure cohort, therefore, is particularly attractive. Data to support its use for this indication are limited to single case reports [16] . Accordingly, we examined the acute and longer term outcomes of a large patient series that underwent ICE-guided PVL closure at our institution.
| M A TE RI A L S A ND M E TH ODS

| Study population
All patients that underwent ICE-guided percutaneous transcatheter PVL closure between 2006 and 2016 at the John Radcliffe Hospital, Oxford, United Kingdom were retrospectively analyzed. All patients were confirmed to have moderate or severe PVL on the basis of echocardiography in combination with attributable congestive cardiac failure and/or significant hemolysis on the basis of clinical examination and laboratory investigation. Hemolytic anemia was defined as a hemoglobin <10 g/dL with evidence of hemolysis (abnormalities on blood smear, raised lactate dehydrogenase, high reticulocyte count, low haptoglobin) requiring blood transfusions with no other cause of blood loss. Aortic leak locations were described in relation to the location of anatomical coronary cusps. Mitral leaks were described by the use of the "clock-face" system in the "surgical view" as previously described [10, 17] . Patients did not routinely undergo preprocedural computed tomography and/or TOE. All patients were discussed by the "Heart
Team" prior to proceeding to percutaneous intervention. ICE guided intervention was decided upon either when TOE was contraindicated, when general anesthesia was deemed to be of high-risk or when unavailable at short notice due to logistic reasons. Written informed consent was obtained from all patients following explanation of all treatment options and procedure-related risks, according to the Declaration of Helsinki. All clinical data during follow-up were collected from hospital visits or telephone consultation.
| Procedure
ICE guidance was typically performed from an RA or RV view. Following insertion of a 9 French (Fr) femoral venous sheath under local anesthesia, ICE images were obtained using an ACUSON AcuNav ultrasound catheter (Siemens Medical Solutions, USA, Inc., Mountain View, CA). ICE guidance was used to visualize the PVL, guide transseptal puncture (if required), aid in device selection and sizing, determine residual PVL prior to definitive device deployment and detect periprocedural complications.
Techniques employed to close PVL are in accordance with those previously published [10, 11] . For periaortic leaks (Figure 1 ), a retrograde approach was generally performed via the femoral artery.
The defect was crossed under ICE and fluoroscopic guidance with steerable diagnostic coronary catheters (e.g., multipurpose, Amplatz left 1 (AL1)) and 0.035 0 guidewire. For perimitral leaks (Figure 2 ), a transseptal puncture was performed via the femoral vein under ICE and fluoroscopic guidance for more lateral leaks (6-10 o'clock on clock face) [18] . If the initial device was not fully occlusive, the decision was made to exchange the device for a larger one or to implant additional small devices. In each case, prosthetic valve function was evaluated prior to deployment of the device.
| Clinical follow-up
All patients were evaluated postprocedure clinically and with transthoracic echocardiography (TTE) prior to discharge and all complications were recorded. All patients were reviewed regularly by clinic visits.
Specifically, information with regards to New York Heart Association (NYHA) class, residual leak, device embolization, presence of hemolytic anemia, requirement for blood transfusion, occurrence of stroke of myocardial infarction, and bacterial endocarditis was noted. For patients that died during the follow-up period, the cause of death was ascertained by review of the clinical record.
| Statistics
Continuous variables are expressed as mean 6 standard deviation (SD). Table 1 .
All patients presented with signs and symptoms consistent with congestive cardiac failure and in addition 4 patients (22.2%) demonstrated objective evidence of active hemolysis. There were no signs of active infection in any patient prior to closure. As expected, the estimated operative mortality was high (logistic EuroSCORE: 23.6 6 12.3, Society of Thoracic Surgeons (STS); mortality estimate: 4 6 2.2).
| Procedural success
All procedures were performed under local anesthesia with ICE guidance and are summarized in Table 2 . At total of 21 ICE-guided PVL closures were attempted in 18 patients during the study period with leaks in biological prostheses (33.3%) and mechanical prostheses (66.6%).
Eleven patients (61.1%) were treated for para-aortic PVL and 7 patients (38.9%) were treated for paramitral PVL.
First-time technical success (defined by a reduction of PVL to <moderate) was achieved in 13 (72.2%) patients. The five patients that were unsuccessfully treated with ICE-guided closure occurred early in our experience. Two patients returned electively and were successfully treated with TOE guided percutaneous closure without further complication. One patient suffered a device embolization following deployment of a 14 3 5 mm Amplatzer vascular plug III to treat a para-aortic leak in to the left ventricle. We were unable to retrieve this percutaneously, and the patient proceeded to successful emergency cardiac surgery and made an uncomplicated recovery. We were unable to cross a para-aortic defect in one patient in spite of excellent visualization with ICE, the patient was managed medically with redo surgery deemed too high-risk. In one patient, we initially attempted an anterograde approach for a lateral paramitral leak, but in spite of excellent visualization and multiple attempts at positioning a device, we were unable to obtain an acceptable position without valve interference. The initial procedure was therefore abandoned but was successfully treated under ICE guidance via a retrograde approach and the implantation of a 5 3 4 mm duct occluder.
There were two periprocedural vascular complications that were self-resolving and required no further intervention. There were no periprocedural instances of acute myocardial infarction, stroke, or death and no ICE-related complications. Procedure times were 86 6 33 min for para-aortic leak closure and 120 6 94 min for paramitral leak closure. During longer term follow-up, two patients were noted to have further progression in PVL following closure associated with a deterioration in symptoms attributable to heart failure. One patient was successfully treated with redo ICE-guided PVL closure, while we were unable to successfully treat the recurrent PVL percutaneously in the second patient who was treated medically due to the risk of surgical repair being too high. One patient presented at 6 month follow-up with increasing breathlessness, echocardiography demonstrated a recurrence of the PVL and late embolization of the device into the iliac artery that was successfully retrieved. A repeat percutaneous closure attempt under general anesthesia and TOE guidance was unsuccessful As per "clock face" from surgical view of mitral valve [11, 18] .
| Follow up
and this patient was also medically treated. Five patients (35.7%) died during the follow-up period, and survival at 1 year was 71.4%.
| D I SCUSSION
The principal findings of this study are as follows: (1 PVL occurs in a reported 2%-15% of patients following surgical valve replacement [1] . Percutaneous closure is now an accepted alternative treatment option to redo surgery for symptomatic patients [10] [11] [12] [13] [14] that often present with multiple co-morbidities. This is most commonly performed with TOE guidance that requires GA that itself is associated with increased procedural risk.
ICE performed via a dedicated catheter has been demonstrated to be useful in both the diagnosis of cardiac pathology [19, 20] and also in the guidance of a number of cardiac interventions including transseptal puncture [21] , patent foramen ovale closure [22] , atrial septal defect closure [22] , ventricular septal defect closure [23] , electrophysiology ablation [24] , and left atrial appendage occlusion [25] . There have previously been single case reports demonstrating the potential of ICE in PVL closure [16] , we here report a large single-center case series. The first-time procedural success rate in our case series was 72.2% with an overall success rate of 77.8% that is similar to previously reported larger case series that used TOE and GA to guide percutaneous closure [10, 11] . Furthermore, there were no complications associated with the use of ICE confirming safety in addition to efficacy of this approach.
There did appear to be a "learning curve" with regards to ICE use for this indication, with a greater failure rate early on in our reported case series. With greater operator experience, we achieved improved rates of procedural success in combination with shorter procedure times. In the setting of a failed procedure, the use of ICE in the index procedure did not preclude either a further attempt with the same approach or a reattempt with the aid of GA and TOE guidance.
ICE is versatile and can provide adequate image quality but is limited by reduced depth penetration that can limit visualization of certain (Figure 3 ) [20] . Using these approaches, we were able to use ICE to guide both para-aortic and paramitral PVL closure when both anterograde and retrograde techniques were utilized (Figures 1 and 2 ).
However, in spite of these man oeuvres, there was one patient who was unable to adequately visual the PVL that was a lateral paramitral defect (patient 3). The patient, however, did return for successful closure under GA and TOE guidance. Finally, the cost of the current single-use catheter is a limitation; however, this is partially offset by reduction in the need of additional staff (e.g., anesthetist) and shorter procedure times. We here demonstrate the safety and efficacy of ICE-guided percutaneous closure and reported the largest case series to date. In the future, with greater operator experience, procedure success rates may further improve in addition to better case selection for this approach and most importantly cases where this approach may not be associated with procedural success (e.g., lateral paramitral leaks).
| Study limitations
This was a retrospective study and the decision to utilize ICE to guide PVL closure was decided by the team on a case-by-case basis and so the impact of selection bias with regards to procedural success rates cannot be excluded. The patient numbers are relatively small and therefore did not allow for statistical analysis to determine predictors of positive procedural and clinical outcomes. We were unable to determine the effect of acute procedural success upon long-term outcomes.
| C ONC LUSI ON
Percutaneous PVL closure guided by ICE without the requirement of general anesthesia is feasible, safe, and associated with acceptable procedural success rates.
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